Deroy & Devereaux Private Investment Counsel Inc. Lowers Stock Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Deroy & Devereaux Private Investment Counsel Inc. reduced its holdings in HCA Healthcare by 1.8%, now owning 117,979 shares valued at approximately $45.2 million, making it their third largest position.
• A variety of institutional investors have modified their stakes in HCA Healthcare, with Tuttle Capital Management LLC increasing its holdings by 14.8% in the second quarter.
• Analysts have mixed ratings on HCA Healthcare, with Cantor Fitzgerald maintaining an "overweight" rating and a target price of $444, while Wolfe Research downgraded the stock from "outperform" to "peer perform."

Deroy & Devereaux Private Investment Counsel Inc. reduced its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1.8% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 117,979 shares of the company's stock after selling 2,139 shares during the quarter. HCA Healthcare accounts for 2.4% of Deroy & Devereaux Private Investment Counsel Inc.'s portfolio, making the stock its 3rd biggest holding. Deroy & Devereaux Private Investment Counsel Inc.'s holdings in HCA Healthcare were worth $45,198,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Tuttle Capital Management LLC lifted its holdings in shares of HCA Healthcare by 14.8% during the second quarter. Tuttle Capital Management LLC now owns 2,046 shares of the company's stock valued at $784,000 after purchasing an additional 264 shares in the last quarter. Ritholtz Wealth Management increased its position in HCA Healthcare by 10.4% during the second quarter. Ritholtz Wealth Management now owns 9,924 shares of the company's stock valued at $3,802,000 after acquiring an additional 932 shares during the last quarter. Sagespring Wealth Partners LLC increased its position in HCA Healthcare by 8.2% during the second quarter. Sagespring Wealth Partners LLC now owns 10,140 shares of the company's stock valued at $3,885,000 after acquiring an additional 769 shares during the last quarter. Morningstar Investment Management LLC purchased a new stake in HCA Healthcare during the second quarter valued at $665,000. Finally, Cornerstone Wealth Group LLC purchased a new stake in HCA Healthcare in the second quarter worth about $232,000. 62.73% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Cantor Fitzgerald reiterated an "overweight" rating and set a $444.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 7th. Weiss Ratings reiterated a "buy (b-)" rating on shares of HCA Healthcare in a research report on Wednesday, October 8th. Wolfe Research lowered HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Bank of America increased their price target on HCA Healthcare from $375.00 to $410.00 and gave the company a "neutral" rating in a research note on Wednesday, September 10th. Finally, Wells Fargo & Company increased their price target on HCA Healthcare from $375.00 to $412.00 and gave the company an "equal weight" rating in a research note on Tuesday, October 7th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and nine have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $431.07.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.30% of the company's stock.

HCA Healthcare Price Performance

NYSE:HCA opened at $418.34 on Wednesday. The firm has a market capitalization of $97.89 billion, a price-to-earnings ratio of 17.58, a PEG ratio of 1.29 and a beta of 1.40. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $439.01. The business has a 50 day simple moving average of $407.16 and a 200-day simple moving average of $376.85.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company's revenue for the quarter was up 6.4% on a year-over-year basis. During the same period last year, the company earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were issued a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare's dividend payout ratio is presently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.